Lifestyle changes and beliefs regarding disease severity in patients with chronic hepatitis C

Journal of Viral Hepatitis

Volumn 13, Issue 7, 2006, Pages 482-488

  Castera, L ^a,b   Constant, A ^c   Bernard, P H ^b   De Ledinghen, V ^a   Couzigou, P ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Anxiety; Diet; Hepatitis C; Lifestyle; Perceived disease severity; Sex life

Indexed keywords

ADULT; AGE; ANXIETY; ARTICLE; CHRONIC HEPATITIS; DIETARY INTAKE; DISEASE SEVERITY; FEMALE; GENDER; HEPATITIS C; HUMAN; LIFESTYLE; LIVER CANCER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; VIRUS LOAD;

EID: 33745222586     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00719.x     Document Type: Article

References (44)

1. Lauer GM Walker BD. Hepatitis C virus infection. N Engl J Med 2001 345: 41 52.
2. Alter MJ Kruszon-Moran D Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999 341: 556 562.
3. Foster GR Goldin RD Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998 27: 209 212.
4. Fontana RJ Kronfol Z. The patient's perspective in hepatitis C. Hepatology 2004 39: 903 905.
5. Bonkovsky HL Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999 29: 264 270.
6. Hunt CM Dominitz JA Bute BP et al. Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life. Dig Dis Sci 1997 42: 2482 2486.
7. Rodger A Jolley D Thompson S et al. The Impact of Diagnosis of Hepatitis C virus on Quality of life. Hepatology 1999 30: 1299 1301.
8. Ware JE Jr. Bayliss MS Mannocchia M et al. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999 30: 550 555.
9. Gallegos-Orozco JF Fuentes AP Gerardo Argueta J et al. Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 2003 34: 124 129.
10. Heitkemper M Jarrett M Kurashige EM et al. Chronic hepatitis C. Implications for health-related quality of life. Gastroenterol Nurs 2001 24: 169 175 quiz 176 177.
11. Leventhal H Diefenbach M Leventhal EA. Illness cognition: using common sense to understand treatment adherence and effect cognition interaction. Cognit Ther Res 1992 16: 143 163.
12. Leventhal H Meyer D Nerenz D. The common-sense representations of illness danger. In: Rachman S, ed. Medical Psychology. New York: Guildford Press, 1980: 7 30.
13. Badruddin SH Jafri SM Ahmed A et al. Dietary practices and beliefs of patients with chronic liver disease. J Pak Med Assoc 1999 49: 216 220.
14. Blanchard CM Denniston MM Baker F et al. Do adults change their lifestyle behaviors after a cancer diagnosis Am J Health Behav 2003 27: 246 256.
15. Mulhern RK Tyc VL Phipps S et al. Health-related behaviors of survivors of childhood cancer. Med Pediatr Oncol 1995 25: 159 165.
16. Pinto BM Clark MM Maruyama NC et al. Psychological and fitness changes associated with exercise participation among women with breast cancer. Psychooncology 2003 12: 118 126.
17. Bengel J Belz-merk M Farin E. The role of risk perception and efficacy cognitions in the prediction of HIV-related preventive behavior and condom use. Psychol Health 1996 11: 505 525.
18. Gallo-Silver L. The sexual rehabilitation of persons with cancer. Cancer Pract 2000 8: 10 15.
19. Hamilton AB. Psychological aspects of ovarian cancer. Cancer Invest 1999 17: 335 341.
20. Siston AK Knight SJ Slimack NP et al. Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology 2003 61: 172 178.
21. Salminen E Bishop M Poussa T et al. Dietary attitudes and changes as well as use of supplements and complementary therapies by Australian and Finnish women following the diagnosis of breast cancer. Eur J Clin Nutr 2004 58: 137 144.
22. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994 20: 15 20.
23. Bruchon-Schweitzer ML Paulhan I. Le Manuel du STAI-Y de CD Spielberger, adaptation française. Paris: ECPA, 1993.
24. Spielberger CD Gorsuch R Lushene R. The State-Trait Anxiety Inventory (STAI, Form Y). Palo Alto, CA: Consulting Psychologists Press, 1983.
25. National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: 2002-June 10-12, 2002. Hepatology 2002 36: S3 20.
26. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002 36: S99 105.
27. Gluud C Wantzin P Eriksen J. No effect of oral testosterone treatment on sexual dysfunction in alcoholic cirrhotic men. Gastroenterology 1988 95: 1582 1587.
28. Marchesini G Bianchi G Amodio P et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001 120: 170 178.
29. Munoz-Sastre MT Bacq Y Mullet E et al. Misconceptions regarding hepatitis C in the French public. Prev Med 2002 34: 596 599.
30. Zarski JP Leroy V. Counselling patients with hepatitis C. J Hepatol 1999 31: 136 140.
31. Hickman IJ Jonsson JR Prins JB et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004 53: 413 419.
32. Hickman IJ Clouston AD Macdonald GA et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002 51: 89 94.
33. Constant A Castera L Quintard B et al. Psychosocial factors associated with perceived disease severity in patients with chronic hepatitis C: relationship with information sources and attentional coping styles. Psychosomatics 2005 46: 25 33.
34. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002 36: S21 29.
35. Marcellin P Asselah T Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 2002 36: S47 56.
36. Mellors JW Rinaldo CR Jr. Gupta P et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996 272: 1167 1170.
37. Roudot-Thoraval F Bastie A Pawlotsky JM et al. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology 1997 26: 485 490.
38. Martinot-Peignoux M Roudot-Thoraval F Mendel I et al. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat 1999 6: 435 443.
39. Bonaccorso S Marino V Biondi M et al. Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J Affect Disord 2002 72: 237 241.
40. Bianchi G Loguercio C Sgarbi D et al. Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment. Dig Liver Dis 2000 32: 398 405.
41. Dieperink E Ho SB Tetrick L et al. Suicidal ideation during interferon-alpha2b and ribavirin treatment of patients with chronic hepatitis C. Gen Hosp Psychiatry 2004 26: 237 240.
42. Koff RS. Impaired health-related quality of life in chronic hepatitis C: the how, but not the why. Hepatology 1999 29: 277 279.
43. Zickmund S Ho EY Masuda M et al. 'They treated me like a leper'. Stigmatization and the quality of life of patients with hepatitis C. J Gen Intern Med 2003 18: 835 844.
44. Hopwood M Treloar C. Receiving a hepatitis C-positive diagnosis. Intern Med J 2004 34: 526 531.